Russian Pharmacies Selling COVID-19 Treatment

According to Reuters reporting on September 18, 2020, R-Pharm’s Coronavir treatment for outpatients with mild to moderate COVID-19 infections will be sold in pharmacies in Russia. R-Pharm stated it received approval for Coronavir after the completion of Phase III clinical trials involving 168 patients diagnosed with COVID-19.

Coronavir was first approved for in-hospital use to treat Russian patients with COVID-19 in July 2020, according to a government registry.

Coronavir is sold under various names around the world, including Avigan, FabiFlu, Avifavir, Ciplenza, FluGuard, Avifavir, and is an active form, favipiravir-RTP (favipiravir ribofuranosyl-5′-triphosphate).